46 /100
MEDIUM RISK
Score updated May 30, 2026

NEUP — Neuphoria Therapeutics Inc. Dilution Risk Tracker

Track NEUP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NEUP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 24 points recently (worsening)
🔔 Track NEUP — Get forecast alerts →

💹 Market Data

Market Cap$28.70M
Shares Outstanding5.40M
Float4.19M
Cash$19.44M
Debt$34.2K
Short InterestN/A

🏛 Institutional Holdings

21 institutional holders · 1.50M shares
#1 Lynx1 Capital Management LP 875.2K shares
#2 Shay Capital LLC 169.1K shares
#3 AdvisorShares Investments LLC 134.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest19.6K
Days to Cover1.0
% of Float0.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NEUP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NEUP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NEUP
📊 NEUP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NEUP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.